to page content
to site navigation
Explore the Entrepreneurship.org Resource Center to find resources. Designed with entrepreneurs in mind, our resource center allows you to find materials to grow great ideas.
Josh Makower, CEO of ExploraMed, speaks briefly about his experience working in medicine and technology. Dr. Makower also discusses at length the numerous political, financial, and regulatory hurdles against future medical innovation, and calls for audience involvement in the tangled web of healthcare, patents, and insurance reimbursement.
Urmee Mehta Mankar is the Deputy COO of Swadhaar. She received her Masters Degree in Urban Planning from the University of Michigan, Ann Arbor, USA, with a specialization in International Development Planning and a
Bachelors Degree in Architecture from CEPT, Ahmedabad, India. She has completed several academic research initiatives dealing with the challenges of urban development.
Mike Maples, Jr. is the managing partner of Maples Investments, and is an entrepreneur in his own right. Before becoming a full-time investor, he worked in a variety of executive and management roles in high-growth
companies. His background spans a variety of markets including consumer technology, small business, and the enterprise, and he has served in various executive roles in product development, marketing, and corporate strategy. Mike began his
technology career in high school, when he started a software company that developed games and educational products for the original IBM PC. He has been passionate about the technology industry ever since. Most recently, Mike co-founded
Motive, Inc., the world's leading broadband software company in 1997 and played key roles in its growth from raw start-up through sales of $100 million. Motive was one of the only successful technology IPOs in 2004, and the most successful
infrastructure software IPO for the prior three years. At Motive, Mike was General Manager of Motive's Corporate Business Unit, as well as Chief Marketing and Strategy officer. Prior to Motive, Mike was responsible for worldwide product
marketing at Tivoli Systems, where he managed the company's product portfolio from its early-stage development through its 1995 IPO and growth to a $750M line of business within the IBM Software Group. Mike began his professional career at
Silicon Graphics, where he served in business development and product marketing roles. In his spare time Mike is an amateur artist, movie-maker, and calligrapher. He holds an Engineering degree from Stanford University, an MBA from Harvard
Business School, and is a frequent speaker at industry conferences and a guest-lecturer on entrepreneurship at Harvard Business School, Stanford University, Princeton University, and the University of Texas.
An international expert in agricultural biotechnology and biopesticide science and business, Pam Marrone, Ph.D., is founder and former Chairman/CEO of AgraQuest Inc. which she established in Davis, CA in 1995. She
recently left AgraQuest to start Marrone Organic Innovations, Inc. which is focused on finding solutions to unmet market needs, especially weed control for organic farmers. AgraQuest researches, develops and markets environmentally
friendly, natural products for farm, home and public health pest management. Marrone's interest in this area began as a child, blossomed into a Ph.D. in entomology, and took flight in 1983 when she became head of the Insect Biology group
for Monsanto Agricultural Co. In 1990, Marrone became president of Entotech, a Davis-based biopesticide subsidiary of Danish company Novo Nordisk. She launched AgraQuest after Entotech was sold to Abbott Laboratories. AgraQuest discovered
Serenade, for controlling diseases of fruits and vegetables, and began selling the biofungicide in late 2000. Marrone and AgraQuest won the 2003 Presidential Green Chemistry award (small business) for the discovery and commercialization of
Serenade and a 2004 Red Herring Top 100 company award. The company also has several other products either in development or on the market. Marrone has raised more than $50 million through private equity investments to fund AgraQuest's
operations. Amid the post-September 11 stock market sell-off, Marrone postponed the company's initial public offering until the window opens again for new biotech investments. Marrone received a BS in entomology from Cornell University and
her Ph.D. from North Carolina State University. Courtesy of Hoover Institution
Mr. Martin joined Pacific Biosciences in 2004 as a seasoned executive with a 25-year track record managing leading edge technologies, new ventures, and high growth businesses. Previously, Mr. Martin was Chairman,
President and CEO of ONI Systems?a high-speed optical telecommunications company he founded in 1998 and took public in 2000. Named the Fastest Growing Company in Silicon Valley in 2001, ONI was sold to Ciena in 2002. After its sale, Mr.
Martin served as a consultant to Ciena, a CEO in residence at the venture capital firm of Kleiner Perkins Caufield and Byers, and was a Director at Cloudshield Technologies. Prior to ONI, Mr. Martin was President and Director of 3DO?an
interactive gaming company. His earlier experience includes running desktop engineering for Apple Computer and founding Ridge Computers?designer of the world's first commercial reduced instruction set computing (RISC) minicomputer. Mr.
Martin received a BS in Electrical Engineering at Rutgers University, New Brunswick, New Jersey. Mr. Martin currently serves on the Board of Directors of Pacific Biosciences and Infinera.
Joe McCracken is Vice President of Business Development at Genentech, Inc. In this role, McCracken is responsible for all business development activities at the company, including the identification and negotiation of
collaboration and licensing agreements with academic institutions, biotechnology companies and pharmaceutical companies throughout the world. After a seven-year absence, McCracken rejoined Genentech in 2000 as Vice President of Business
Development. During his earlier time with Genentech, McCracken served in many capacities, culminating in positions as Director of Business Development and Representative Director of Genentech Ltd., Genentech's wholly owned subsidiary in
Japan. McCracken has more than 19 years of experience in technical, business development and market development roles with biotechnology and pharmaceutical companies. He has also served as Vice President of Technology Licensing and
Alliances at Aventis, and Vice President of Worldwide Business and Technology Development at Rhone-Poulenc Rorer S.A.
William McDonough is an internationally renowned designer and one of the primary proponents and shapers of what he and his partners call 'The Next Industrial Revolution.' Time magazine recognized him
in 1999 as a 'Hero for the Planet', stating that "his utopianism is grounded in a unified philosophy that-in demonstrable and practical ways-is changing the design of the world." Time magazine again recognized Mr.
McDonough and Michael Braungart as "Heroes of the Environment" in October 2007. In 1996, Mr. McDonough received the Presidential Award for Sustainable Development, the nation's highest environmental honor; and in 2003 earned the U.S. EPA
Presidential Green Chemistry Challenge Award. In 2004 he received the National Design Award for exemplary achievement in the field of environmental design. In October 2007, Mr. McDonough was elected an International Fellow of the Royal
Institute of British Architects. Mr. McDonough is the founding principal of William McDonough + Partners, an internationally recognized design firm practicing ecologically, socially, and economically intelligent architecture and planning
in the U.S. and abroad. He is also principal of MBDC, a product and systems development firm assisting prominent client companies in designing profitable and environmentally intelligent solutions. Mr. McDonough is a Venture Partner at
VantagePoint Venture Partners in San Bruno, California. Mr. McDonough is an Alumni Research Professor at the University of Virginia's Darden Graduate School of Business Administration, and Consulting Professor of Civil and Environmental
Engineering at Stanford University. He also serves as U.S. Chairman and member of the Board of Councilors of the China-U.S. Center for Sustainable Development. He is part of the Management Committee of HRH The Prince of Wales's Business
& The Environment Programme at Cambridge University. From 1994-1999, Mr
Roger McNamee is a Managing Director and Co-Founder of Elevation Partners. Prior to Elevation, Roger was a co-founder of Silver Lake Partners, the leading private equity fund focused on technology and related growth
industries. He was a member of Silver Lake's Investment Committee and was involved in all aspects of that partnership. Prior to Silver Lake, Roger was a co-founder of Integral Capital Partners. Integral is a leading technology investor in
late-stage venture and public company investments. Founded in 1991 by Roger, John A. Powell, and Kleiner Perkins Caufield & Byers, Integral pioneered the crossover investment strategy, which seeks maximum capital appreciation by making
investments in expansion-stage private companies and growth-stage public companies in the technology and life science industries. Prior to founding Integral, Roger managed the T. Rowe Price Science & Technology Fund and co-managed the
T. Rowe Price New Horizons Fund, which was at that time the largest emerging growth fund in the U.S. Roger serves as a trustee of Bryn Mawr College, an overseer of the Amos Tuck School of Business Administration at Dartmouth College, and a
director of the Rex Foundation. Roger holds a B.A. from Yale College and an M.B.A. from the Amos Tuck School of Business Administration at Dartmouth College.
John G. Melo is the Chief Executive Officer of Amyris Biotechnologies, a synthetic biology company working to reduce the cost of curing malaria and producing lower carbon, second generation bio-fuels. He was previously
president of U.S. Fuels for BP, where he led one of the world's largest petroleum marketing, logistics, and trading businesses. While in this role he successfully grew revenues from $25 billion to $34 billion and increased net cash by $1
billion. During this time his team developed one of the world's most successful ethanol blending and marketing businesses. He also worked on the development of BP's "Helios" re-branding. Prior to his eight years with BP, Mr. Melo was a
director with Ernst & Young in San Jose, California, and a management team member for several Northern California start-ups, including Computer Aided Services and Alldata Corporation. John serves on the Board of Directors for U.S. Oil,
a $1.6 billion energy company, and Cilion, a leading low-cost ethanol manufacturer. John is a member of the Economic Club of Chicago, The Chicago Club, The Chicago Council on Global Affairs, and YPO. He enjoys visiting his home country of
Azores, Portugal, as well as skiing, biking, tennis, golf, and time with his children.
Stanford Engineering lecturer and FLOODGATE partner Ann Miura-Ko offers insight into the democratization of innovation in the Internet age, and its affect on investment cycles. Additionally, Miura-Ko speaks candidly about the need to test business models, her firm's desire to be an advocate for "thunder lizard" entrepreneurs, and the challenges of achieving true work/life balance.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
A robust online curriculum for entrepreneurs.
Explore Founders School >
A network of U.S. cities facilitating a weekly entrepreneur education program. Go to 1 Million Cups >
Whether you are starting or growing a company, FastTrac will help you live your dream at each stage.
Get started with FastTrac >